Skip to main content
. 2021 Jul 7;67(1):65–67. doi: 10.1038/s10038-021-00958-2

Table 1.

Association analyses of PIEZO1 E756del (rs59446030) with severe malaria in the Ghanaian case-control study

SM study groupa ntotal = 4149
SM cases n = 2413 (%) Controls n = 1736 (%) Odds ratiob, 95% CI, p value
PIEZO1 E756 genotype
WT/WT 1483 (61.5) 1037 (59.8) Ref
WT/del 699 (29.0) 523 (30.1) 0.91 (0.79–1.05) p = 0.19
del/del 91 (3.8) 85 (4.9) 0.71 (0.52–0.98) p = 0.04
WT/ins 107 (4.4) 70 (4.0) 1.04 (0.75–1.42) p = 0.83
del/ins 25 (1.0) 16 (0.9) 1.17 (0.61–2.24) p = 0.63
ins/ins 8 (0.3) 5 (0.3) 1.26 (0.40–3.94) p = 0.70
Hemoglobin type
HbAA 2128 (88.4) 1,314 (75.8) Ref
HbAS 34 (1.4) 263 (15.2) 0.08 (0.05–0.12) p < 0.00001
HbAC 239 (9.9) 148 (8.5) 0.34 (0.12–0.99) p = 0.05
HbCC 6 (0.3) 9 (0.5) 0.93 (0.75–1.17) p = 0.55
Median age, months (range) 20 (7–117) 30 (7–116)
Sex (female, %) 46.1 47.1
Ethnic group, n (%)
Akan 1605 (66.5) 1260 (72.6)
Northerner 698 (28.9) 442 (25.4)
Ewe 73 (3.1) 24 (1.4)
Ga 37 (1.5) 10 (0.6)

SM severe malaria, CI confidence interval.

aSevere malaria case group includes discrete and partly overlapping phenotypes, severe malaria anemia defined as hemoglobin level <5 g/dl, cerebral malaria defined as Blantyre coma score <3, and hyperlactatemia; prostration, hyperparasitemia, respiratory distress.

bResults of logistic regression adjusted for age, sex and ethnic group.